Ryan Companion Robot for Assisting Elderly People With Alzheimer's Disease

Status Completed

Clinical Trial Summary

The objective of this project is to conduct research and a pilot study to demonstrate the potential clinical impact and technical feasibility of a socially-assistive robot, called Ryan Companionbot (hereafter Ryan), for life improvement and intervention of persons with early stage Alzheimer's disease (AD) and AD related dementia (ADRD). Earlier phases of this project demonstrated the feasibility and scalability of using emotion recognition technology based on cutting-edge natural language processing and artificial intelligence technologies to improve mood and lessen depression symptoms of persons with early stage AD/ADRD. In this phase, the investigators will utilize an aesthetically pleasing updated Ryan (V2.0) with emotion recognition and natural language processing for enhanced conversations to address the needs of the individuals with AD/ADRD and their healthcare providers as well as to test the effectiveness of Ryan by comparing participants pre- and post-treatment by analyzing several blood biomarkers related to AD/ADRD and depression. The investigators will recruit thirty participants from local senior living facilities based on their cognitive performance as assessed by the Saint Louis University Mental Status (SLUMS) score. SLUMS is commonly used as a simple screening/assessment test in senior living facilities. As part of the recruitment, the investigators will show prospective participants a video recording of a previous senior volunteer interacting with Ryan to give new recruits an idea of the socially assistive robot technology.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05052866
Study type	Interventional
Source	DreamFace Technologies, LLC
Contact
Status	Completed
Phase	N/A
Start date	April 21, 2021
Completion date	May 30, 2022

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03625401` - Efficacy and Safety of AD-35 in Treatment of Subjects With Mild to Moderate Alzheimer's Disease	Phase 2
Recruiting	`NCT05983575` - A Pivotal Study of LIPUS-Brain in Patients With Early Alzheimer's Disease	Phase 3
Completed	`NCT05989087` - The Resting-state EEG Gamma Oscillations in Alzheimer's Disease
Recruiting	`NCT06080659` - Network-based biOmarker Discovery of Neurodegenerative Diseases Using Multimodal Connectivity	N/A
Not yet recruiting	`NCT06099587` - MIMA Pilot Study: MIcrostructure of the Medial Temporal Lobe in Early Alzheimer's Disease	N/A
Not yet recruiting	`NCT05604183` - Hyperspectral Retinal Observations for the Cross-sectional Detection of Alzheimer's Disease	N/A
Withdrawn	`NCT03514875` - Effects of Mitochondrial-targeted Antioxidant on Mild Cognitive Impairment (MCI) Patients	N/A
Recruiting	`NCT06203106` - NYSCF Scientific Discovery Biobank
Completed	`NCT03706885` - Efavirenz for Patients With Alzheimer's Disease	Phase 1
Active, not recruiting	`NCT03661034` - Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)	N/A
Not yet recruiting	`NCT05006599` - SNIFF - 3-Week Aptar CPS Device	Phase 2
Recruiting	`NCT02740634` - Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study	N/A
Active, not recruiting	`NCT03069391` - The Interactive Physical and Cognitive Exercise System	N/A
Recruiting	`NCT04701957` - The Ketogenic Diet for Alzheimer's Disease	N/A
Recruiting	`NCT06268886` - Study to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's Disease	Phase 2
Recruiting	`NCT04100889` - A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer's Disease
Recruiting	`NCT04656860` - Juice Plus Supplement Clinical Trial	N/A
Recruiting	`NCT05315895` - The Dampness Syndrome of Chinese Medicine Cohort Study
Recruiting	`NCT04916964` - Adapted Home-based Exercise Program "T&E" (Test-and-Exercise) in Persons With Alzheimer's Disease (HOPE Trial)	N/A
Recruiting	`NCT04804618` - Proteomics Study of Mild Cognitive Impairment and Alzheimer's Disease